Ethic Inc. raised its holdings in Amdocs Limited (NASDAQ:DOX – Free Report) by 117.4% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 22,384 shares of the technology company’s stock after purchasing an additional 12,090 shares during the quarter. Ethic Inc.’s holdings in Amdocs were worth $1,280,000 as of its most recent SEC filing.
Several other large investors also recently made changes to their positions in DOX. Pzena Investment Management LLC lifted its position in Amdocs by 3.4% during the 3rd quarter. Pzena Investment Management LLC now owns 14,454,911 shares of the technology company’s stock worth $826,532,000 after buying an additional 469,581 shares in the last quarter. Dimensional Fund Advisors LP raised its stake in shares of Amdocs by 19.7% in the first quarter. Dimensional Fund Advisors LP now owns 3,463,797 shares of the technology company’s stock worth $226,045,000 after acquiring an additional 571,036 shares during the last quarter. Bank of America Corp DE raised its stake in shares of Amdocs by 29.1% in the first quarter. Bank of America Corp DE now owns 1,262,263 shares of the technology company’s stock worth $82,375,000 after acquiring an additional 284,435 shares during the last quarter. First Trust Advisors LP lifted its position in shares of Amdocs by 13.9% during the first quarter. First Trust Advisors LP now owns 1,077,258 shares of the technology company’s stock worth $70,302,000 after purchasing an additional 131,197 shares in the last quarter. Finally, Pacer Advisors Inc. lifted its position in shares of Amdocs by 41.6% during the first quarter. Pacer Advisors Inc. now owns 448,722 shares of the technology company’s stock worth $29,284,000 after purchasing an additional 131,913 shares in the last quarter. Institutional investors own 92.02% of the company’s stock.
Amdocs Stock Performance
Shares of DOX opened at $44.79 on Friday. The company has a market cap of $4.84 billion, a PE ratio of 9.59, a price-to-earnings-growth ratio of 1.44 and a beta of 0.42. The firm has a 50-day moving average of $57.51 and a 200-day moving average of $60.98. Amdocs Limited has a one year low of $39.96 and a one year high of $84.95. The company has a debt-to-equity ratio of 0.23, a current ratio of 0.94 and a quick ratio of 0.94.
Amdocs (NASDAQ:DOX – Get Free Report) last issued its earnings results on Tuesday, November 3rd. The technology company reported $1.98 EPS for the quarter, hitting the consensus estimate of $1.98. The company had revenue of $1.19 billion during the quarter, compared to the consensus estimate of $1.19 billion. Amdocs had a return on equity of 20.81% and a net margin of 10.59%. The firm’s revenue for the quarter was up 3.8% compared to the same quarter last year. During the same period in the previous year, the company posted $1.83 EPS. As a group, equities analysts forecast that Amdocs Limited will post 5.82 earnings per share for the current year.
Amdocs Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, January 29th. Stockholders of record on Thursday, December 31st will be given a $0.5690 dividend. The ex-dividend date of this dividend is Thursday, December 31st. This represents a $2.28 annualized dividend and a dividend yield of 5.1%. Amdocs’s dividend payout ratio is presently 48.82%.
Insider Activity
In other news, insider Shimie Hortig sold 7,264 shares of the stock in a transaction that occurred on Tuesday, November 10th. The stock was sold at an average price of $42.18, for a total transaction of $306,395.52. Following the transaction, the insider owned 174,432 shares in the company, valued at approximately $7,357,541.76. This trade represents a 4.00% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director John Anthony Macdonald purchased 1,000 shares of the company’s stock in a transaction that occurred on Tuesday, November 10th. The shares were purchased at an average cost of $41.63 per share, with a total value of $41,630.00. Following the completion of the acquisition, the director owned 25,189 shares in the company, valued at $1,048,618.07. The trade was a 4.13% increase in their position. The SEC filing for this purchase provides additional information. Over the last quarter, insiders have bought 3,534 shares of company stock valued at $147,966. 15.40% of the stock is owned by insiders.
Analysts Set New Price Targets
A number of analysts recently weighed in on the stock. Weiss Ratings raised shares of Amdocs from a “sell (d+)” rating to a “hold (c-)” rating in a report on Friday, October 23rd. Zacks Research cut Amdocs from a “hold” rating to a “strong sell” rating in a research note on Monday, November 9th. Oppenheimer lowered shares of Amdocs from an “outperform” rating to a “market perform” rating in a report on Wednesday, November 4th. Wall Street Zen lowered Amdocs from a “buy” rating to a “hold” rating in a report on Saturday, November 7th. Finally, Stifel Nicolaus reduced their target price on Amdocs from $71.00 to $46.00 and set a “buy” rating on the stock in a report on Wednesday, November 4th. Two investment analysts have rated the stock with a Buy rating, three have assigned a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat, Amdocs currently has a consensus rating of “Hold” and an average target price of $69.00.
Get Our Latest Research Report on DOX
Recent Amdocs Headlines
Here are a few of the latest headlines about DOX:
- Positive Sentiment: Three directors reported purchases of Amdocs shares, including Yvette Kanouff’s $100,800 purchase and John Anthony Macdonald’s $41,630 purchase. These transactions may signal confidence in the company, although insider buying is not a guarantee of future performance. SEC filing
- Positive Sentiment: Amdocs is seeking shareholder approval for a 3% quarterly dividend increase, which could bolster its appeal to income-focused investors. Dividend proposal
- Negative Sentiment: Insider Shimie Hortig sold 8,997 shares across transactions on November 10 and 11, reducing his holdings. The sales may weigh on sentiment, though he retained a substantial position. SEC filing
About Amdocs
Amdocs provides software and services to communications and media companies. Its offerings include business and operational support systems for billing, customer management, service delivery and network operations, as well as cloud and digital solutions that help clients modernize their businesses and improve customer experiences. Founded in 1982, Amdocs serves communications and media providers in markets around the world. The company is headquartered in the St. Louis, Missouri, area and is led by President and Chief Executive Officer Shuky Sheffer.
Further Reading
- Five stocks we like better than Amdocs
- Nu Holdings Earnings Show a Compounder Priced Like a Brazil Bet
- Game On: The Hidden Value in Take-Two’s Stock
- LightPath Technologies’ Record Backlog Highlights a Bigger Defense Opportunity
- A 10-Stock Strategy That Balances AI Growth With Cash Flow
Want to see what other hedge funds are holding DOX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amdocs Limited (NASDAQ:DOX – Free Report).
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.
